Thumbnails similares a FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD

20 vecinos (thumb_512) · 123 views · HCPLive · Estados Unidos


★	FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD	HCPLive @hcplivenews	123	Estados Unidos
5	Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome	HCPLive @hcplivenews	2.0K	Estados Unidos	69
14	Why Glucose Alone Isn't Enough: The Future of Ketone Monitoring in Diabetes	HCPLive @hcplivenews	475	Estados Unidos	66
10	One Year of Brensocatib: How Bronchiectasis Care Has Changed	HCPLive @hcplivenews	399	Estados Unidos	67
13	Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment	HCPLive @hcplivenews	374	Estados Unidos	67
8	GP-SOD Plus Targeted Phototherapy Improves Vitiligo Repigmentation	HCPLive @hcplivenews	249	Estados Unidos	68
15	Continuous Glucose Monitoring in Type 2 Diabetes, With John Anderson, MD	HCPLive @hcplivenews	196	Estados Unidos	66
19	SYNCHRONIZE-1: Survodutide Achieves Significant Weight Loss Versus Placebo	HCPLive @hcplivenews	174	Estados Unidos	65
17	GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD	HCPLive @hcplivenews	151	Estados Unidos	66
1	FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD	HCPLive @hcplivenews	131	Estados Unidos	76
18	Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk	HCPLive @hcplivenews	120	Estados Unidos	65
2	SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes	HCPLive @hcplivenews	86	Estados Unidos	73
3	Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD	HCPLive @hcplivenews	68	Estados Unidos	71
20	Saroglitazar Targets Bile Acid Dysregulation, Inflammation in PBC, With Raj Vuppalanchi, MD	HCPLive @hcplivenews	55	Estados Unidos	65
11	Primary Aldosteronism More Common Than Previously Believed, Requires Increased Screening	HCPLive @hcplivenews	47	Estados Unidos	67
12	Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment	HCPLive @hcplivenews	46	Estados Unidos	67
9	Diagnosing Non-IgE Food Hypersensitivity \| Brian Lacy, MD, PhD \| EAC 2026	HCPLive @hcplivenews	31	Estados Unidos	67
4	Abdominal Pain and Bloating: Recognizing HAE, MCAS, and Eosinophilic GI Disorders \| Brian Lacy, MD	HCPLive @hcplivenews	20	Estados Unidos	69
7	Time to Minimum Residual C-Peptide As a Predictor of Treatment Efficacy in T1D	HCPLive @hcplivenews	16	Estados Unidos	68
16	What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD	HCPLive @hcplivenews	12	Estados Unidos	66
6	Mitraa-T1D: AI-Driven Converastional Tool Improves T1D Diabetes Distress, Self-Care Behaviors	HCPLive @hcplivenews	9	Estados Unidos	68